What is Kose's biggest risk right now?

The biggest risk is that profits are falling much faster than sales are growing. Nine month FY2025 operating profit dropped 27.8% year over year to Y13.575 billion (as of 2025-09-30), and that decline steepened to an 84.5% drop in Q1 FY2026 (as of 2026-03-31), even though full year FY2025 net sales rose 2.30% to Y330.19 billion (as of 2025-12-31). A verifiable watch item is whether Kose cuts guidance for its Tarte brand a second time before FY2026 full results, expected by February 2027.

Is Kose in financial trouble?

Kose is not in acute distress but its earnings trend is weakening. Sales are still growing, up 2.30% to Y330.19 billion in FY2025 (as of 2025-12-31), yet operating profit has fallen in four consecutive reported periods, including an 84.5% year over year drop in Q1 FY2026 (as of 2026-03-31). This gap between rising revenue and shrinking profit is the main reason its standing is listed as defensible for now rather than clearly stable.

Who are Kose Corporation's biggest competitors?

Shiseido is the closest and toughest domestic rival, outselling Kose in Japan skincare 13% to 12% and in premium beauty 21% to 14% (as of 2025-12-31 data cited in the 2026 assessment). Amorepacific is a competitor on innovation rather than volume, having won a CES 2025 Innovation Award for a generative AI makeup tool and returned with a Samsung AI feature at CES 2026. Kao is a competitor Kose currently leads, holding 12% Japan skincare share versus Kao's 7%.

Is Kose at risk from AI?

The AI risk to Kose looks limited for now. Amorepacific has shipped generative AI skin diagnosis and virtual makeup tools, including the WANNA-BEAUTY line, and won a CES 2025 Innovation Award for its generative AI makeup tool, returning with a Samsung AI feature at CES 2026. Kose's own AI mite scanner has shown no disclosed revenue impact. Kose's exposure sits more in falling behind on AI-driven differentiation than in AI directly displacing its business.

How does Kose rank among its industry peers?

Kose sits in the middle of its cosmetics peer group. It trails Shiseido in Japan skincare share (12% vs 13%) and premium beauty share (14% vs 21%), but leads Kao in Japan skincare share (12% vs 7%). Its portfolio spans skincare, premium, and mass-market brands, including Tarte in the US, giving it broader diversification than several of its peers.

What gives Kose an edge over competitors?

Kose's main edge is portfolio breadth, spanning skincare, premium, and mass-market brands, plus owned factories and decades-old counters inside Japanese department stores. This diversification helps it withstand competitive pressure better than several peers in its group. It also outperforms Kao in Japan skincare share, 12% versus 7%, even as it trails category leader Shiseido in both Japan skincare (12% vs 13%) and premium beauty (14% vs 21%).

Consumer brands · Japan

Kose Corporation

kose.co.jp ↗

Kose is an 80-year-old Japanese cosmetics maker selling skincare and prestige beauty through department stores and duty-free.

Defensible for now

Assessed 31 July 2026 · Evidence as of 31 July 2026

Real protection, with named pressure against it.

On the recordSince 31 July 2026 · Checkable from August 12, 2026 · Every call on the record Checkpoint: Q2/Q3 FY2026 earnings report, will show if the profit collapse was one-time restructuring noise

The call

Kose stays profitable and independent for now, but a new non-family president, a holding-company split, and a battered travel-retail business are colliding at once.

Kosé makes face creams, skincare, and makeup sold mainly in Japan and Asia through department stores and airports. It is hard to copy because it owns special recipes, has government approvals for medical-type products in Japan, and sells through loyal store partners that prefer its brands. However, bigger rivals like Shiseido and L'Oréal have deeper pockets and global reach, and younger shoppers increasingly buy from online sellers and direct-to-consumer brands instead of traditional stores. The company's profit dropped 84 percent in early 2026, travel retail sales fell sharply, and new leadership is taking over in March 2026, so the next few earnings reports will show whether this was a one-time stumble or the start of a real problem.

Why

AI pressure: L'Oréal's ModiFace and AI-driven shade-matching/skin-diagnostic apps. Rivals ship AI skin scanners and virtual try-on; Kose has no comparable consumer AI tool, risking digital-native shoppers. Could AI do the core job? Unlikely.

Bigger players: Shiseido, L'Oréal, Estee Lauder, Kao. Bigger, more diversified rivals already compete for the same department-store and travel-retail shelf space Kose depends on. Could a giant copy it? Probably.

What protects it. Proprietary formulation patents, Japan's quasi-drug approval process, and decades-deep department-store and duty-free ties.

What would change this call

Kose's August 12, 2026 Q2/Q3 earnings show operating profit recovery or continued decline. Whether Q1's 84.5% profit collapse was one-time restructuring noise or a structural problem.
China's Hainan duty-free reorganization outcomes over the next two quarters. Whether Kose's Asia travel-retail sales stabilize or keep falling as in FY2025's 19.2% drop.
Tarte North America sales and profitability figures in upcoming Kose filings. Whether Kose's US brand keeps losing ground after its ¥3.4bn sales-plan cut.

Key numbers

FY2025 net sales rose to ¥330.1bn (2025-12-31)
Q1 FY2026 operating profit fell 84.5% YoY (2026-03-31)
Asia travel retail sales fell 19.2% YoY in FY2025 (2025-12-31)

Named risks

Q1 FY2026 operating profit collapsed 84.5% YoY, unclear if restructuring noise or structural decline. Severity: high
Asia travel-retail and China duty-free channel disruption cut sales 19.2% YoY in FY2025. Severity: high
Tarte's North America/Europe underperformance forced a ¥3.4bn sales plan cut in H1 2025. Severity: medium
Concurrent holding-company split and first non-family president create execution uncertainty. Severity: medium
Smaller scale than Shiseido, Kao, and L'Oréal limits investment capacity in prestige and travel-retail competition. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Shiseido	contesting	Similarly positioned Japanese prestige incumbent, larger scale, both battling China travel-retail weakness through 2025-2026
China Tourism Group Duty Free (CDFG)	losing to	Kose Asia travel-retail sales fell 19.2% YoY in FY2025 amid duty-free channel restructuring
Estée Lauder / L'Oréal	losing to	Tarte's North America/Europe sales plan cut ¥3.4bn in H1 FY2025 (reported Aug 21, 2025)
Kao Corporation	contesting	Larger diversified Japanese personal-care rival competing in mass and prestige cosmetics segments

Questions people ask

What is Kose's biggest risk right now?: The biggest risk is that profits are falling much faster than sales are growing. Nine month FY2025 operating profit dropped 27.8% year over year to Y13.575 billion (as of 2025-09-30), and that decline steepened to an 84.5% drop in Q1 FY2026 (as of 2026-03-31), even though full year FY2025 net sales rose 2.30% to Y330.19 billion (as of 2025-12-31). A verifiable watch item is whether Kose cuts guidance for its Tarte brand a second time before FY2026 full results, expected by February 2027.
Is Kose in financial trouble?: Kose is not in acute distress but its earnings trend is weakening. Sales are still growing, up 2.30% to Y330.19 billion in FY2025 (as of 2025-12-31), yet operating profit has fallen in four consecutive reported periods, including an 84.5% year over year drop in Q1 FY2026 (as of 2026-03-31). This gap between rising revenue and shrinking profit is the main reason its standing is listed as defensible for now rather than clearly stable.
Who are Kose Corporation's biggest competitors?: Shiseido is the closest and toughest domestic rival, outselling Kose in Japan skincare 13% to 12% and in premium beauty 21% to 14% (as of 2025-12-31 data cited in the 2026 assessment). Amorepacific is a competitor on innovation rather than volume, having won a CES 2025 Innovation Award for a generative AI makeup tool and returned with a Samsung AI feature at CES 2026. Kao is a competitor Kose currently leads, holding 12% Japan skincare share versus Kao's 7%.
Is Kose at risk from AI?: The AI risk to Kose looks limited for now. Amorepacific has shipped generative AI skin diagnosis and virtual makeup tools, including the WANNA-BEAUTY line, and won a CES 2025 Innovation Award for its generative AI makeup tool, returning with a Samsung AI feature at CES 2026. Kose's own AI mite scanner has shown no disclosed revenue impact. Kose's exposure sits more in falling behind on AI-driven differentiation than in AI directly displacing its business.
How does Kose rank among its industry peers?: Kose sits in the middle of its cosmetics peer group. It trails Shiseido in Japan skincare share (12% vs 13%) and premium beauty share (14% vs 21%), but leads Kao in Japan skincare share (12% vs 7%). Its portfolio spans skincare, premium, and mass-market brands, including Tarte in the US, giving it broader diversification than several of its peers.
What gives Kose an edge over competitors?: Kose's main edge is portfolio breadth, spanning skincare, premium, and mass-market brands, plus owned factories and decades-old counters inside Japanese department stores. This diversification helps it withstand competitive pressure better than several peers in its group. It also outperforms Kao in Japan skincare share, 12% versus 7%, even as it trails category leader Shiseido in both Japan skincare (12% vs 13%) and premium beauty (14% vs 21%).

Timeline

2026-05-14Q1 FY2026 results filed showing operating profit down sharply YoY
2026-03-01Koichi Shibusawa becomes President and Group COO, first non-family president in 19 years
2026-02-12FY2025 results reported, FY2026 guidance set at ¥350bn sales and ¥20bn operating profit
2026-01-16DECORTÉ launches WHITELOGIST CHRONOGENESIS brightening serum, 8th generation
2026-01-01Corporate split creates KOSÉ Holdings Corporation and new operating KOSÉ Corporation
2025-08-21H1 FY2025 results show sales up 0.9%, operating profit down 17.7%, Tarte plan cut ¥3.4bn
2024-04-29DECORTÉ launches Perfect Corp AI skin-diagnostic tool on US e-commerce site
1946-03Company founded by Kozaburo Kobayashi

Head to head

Kao Corporation vs Kose Corporation

Revision history

31 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Estée Lauder LVMH Moet Hennessy Louis Vuitton Chow Sang Sang Holdings International Limited